Vivo Capital, LLC

Open in PORT →← all managers

CIK 1674712

13F portfolio (2026-Q1)

$1.2B

Positions

Implied 1Y CAGR

modeled · as filed

Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.

Implied return what this book implies · modeled, not advice methodology →

Open in PORT →

As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).

Computing…

Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.

Exposures · what this manager owns, by sector & size (2026-Q1)

Holdings

Top 5

41.0%

Top 10

59.3%

Effective N

17.6

HHI

0.057

This quarter

8 new · 0 exit →

By sector

Health Care88.3%

Unclassified11.7%

By market cap

Mid ($2–10B)46.9%

Small ($300M–2B)22.6%

Unknown17.3%

Micro (<$300M)13.2%

By region

North America88.3%

Other11.7%

By industry group GICS — finer than sector

Industry group	Weight	Names
Pharmaceuticals & Biotechnology	87.99%	41
Unclassified	11.74%	4
Health Care Providers & Services	0.28%	1

Top holdings

#	Ticker	Name	Sector	Weight
1	ERAS	Erasca, Inc.	Health Care	16.34%
2	PRAX	Praxis Precision Medicines, Inc.	Health Care	9.08%
3		TERNS PHARMACEUTICALS INC	Unclassified	5.85%
4	TRVI	Trevi Therapeutics, Inc.	Health Care	5.05%
5	DBVT	DBV Technologies S.A.	Health Care	4.63%
6	CMPX	Compass Therapeutics, Inc.	Health Care	4.20%
7	TNGX	Tango Therapeutics, Inc.	Health Care	3.75%
8	SABS	SAB Biotherapeutics, Inc.	Health Care	3.64%
9	CRVS	Corvus Pharmaceuticals, Inc.	Health Care	3.41%
10	DRUG	BRIGHT MINDS BIOSCIENCES INC.	Health Care	3.38%

42/46 names classified · sector 88.3% of weight · industry 88.3% · mkt cap 82.7%; unclassified names shown, never dropped.

Sector allocation over time · how the GICS mix & top names shifted quarter by quarter

top 5/sector, rest → “Other” · 41 quarters

Health CareASND, ACRS, HRMY, ALXO, ERAS · other

Materials

UnclassifiedSOLENO THERAPEUTICS INC, SVA, Aclaris Therapeutics, Inc., SAGENT PHARMACEUTICALS INC, Ascendis Pharma A/S · other

Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 88.3% of the book is sector-classified (unclassified names shown, never dropped).

Style box · size × value-growth placement of the reported book (2026-Q1), classified on current fundamentals (not point-in-time) — load it into PORT to overlay your own portfolio

Only 0% of book weight classified — the grid is NOT representative of the whole book.

holdings, colored by sector (0 classified)Vivo Capital, LLC centroid

Style box summary for Vivo Capital, LLC: no centroid.

Classified: 0.0% of book weight (0/45 names) · unclassified 100.0%: ERAS, PRAX, , TRVI, DBVT, CMPX, TNGX, SABS, CRVS, DRUG +35 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.

Contribution holdings-based, any period

No contribution data for this period.

Holdings· 46 positions (2026-Q1) · largest first · Δ vs 2025-Q4

#	Security	Shares	Value	Weight	Δ QoQ
1	ERASERASCA INC	12,151,480	$197M	16.3%	ADD 31%
2	PRAXPRAXIS PRECISION MEDICINES I	338,895	$109M	9.1%	ADD 3%
3	TERNS PHARMACEUTICALS INC	1,334,418	$70M	5.8%	TRIM −75%
4	TRVITREVI THERAPEUTICS INC	5,094,668	$61M	5.1%	HOLD
5	DBVTDBV TECHNOLOGIES S A	2,667,569	$56M	4.6%	ADD 8%
6	CMPXCOMPASS THERAPEUTICS INC	9,545,466	$50M	4.2%	HOLD
7	TNGXTANGO THERAPEUTICS INC	2,154,780	$45M	3.7%	HOLD
8	SABSSAB BIOTHERAPEUTICS INC	11,420,000	$44M	3.6%	HOLD
9	CRVSCORVUS PHARMACEUTICALS INC	2,805,816	$41M	3.4%	ADD 26%
10	DRUGBRIGHT MINDS BIOSCIENCES INC	557,172	$41M	3.4%	ADD 11%
11	SVASINOVAC BIOTECH LTD	5,903,000	$38M	3.2%	HOLD
12	DNTHDIANTHUS THERAPEUTICS INC	353,998	$30M	2.5%	HOLD
13	DYNDYNE THERAPEUTICS INC	1,557,466	$28M	2.3%	TRIM −40%
14	ABVXABIVAX SA	239,539	$27M	2.2%	TRIM −33%
15	NERVMINERVA NEUROSCIENCES INC	4,322,747	$26M	2.2%	HOLD
16	ACRSACLARIS THERAPEUTICS INC	6,666,666	$25M	2.1%	TRIM −25%
17	ORICORIC PHARMACEUTICALS INC	1,848,786	$23M	1.9%	TRIM −13%
18	ANROALTO NEUROSCIENCE INC	1,035,551	$23M	1.9%	HOLD
19	FTHSENSEI BIOTHERAPEUTICS INC	722,020	$23M	1.9%	NEW
20	AVBPARRIVENT BIOPHARMA INC	885,916	$20M	1.7%	NEW
21	LBRXLB PHARMACEUTICALS INC	800,000	$20M	1.6%	HOLD
22	MANEVeradermics Inc	300,000	$19M	1.6%	NEW
23	CAMPCAMP4 THERAPEUTICS CORP	4,246,568	$19M	1.6%	HOLD
24	MLTXMOONLAKE IMMUNOTHERAPEUTICS	1,000,000	$19M	1.5%	HOLD
25	DSGNDESIGN THERAPEUTICS INC	1,612,903	$17M	1.4%	HOLD
26	COGTCOGENT BIOSCIENCES INC	422,300	$16M	1.4%	TRIM −82%
27	GERNGERON CORP	8,671,797	$13M	1.1%	TRIM −68%
28	UNCYUNICYCIVE THERAPEUTICS INC	1,789,916	$12M	1.0%	HOLD
29	ANTXAN2 THERAPEUTICS INC	3,153,640	$11M	0.9%	NEW
30	OLMAOLEMA PHARMACEUTICALS INC	671,843	$10M	0.8%	HOLD
31	SOLENO THERAPEUTICS INC	294,909	$10M	0.8%	TRIM −67%
32	EPRXEupraxia Pharmaceuticals Inc	1,350,000	$10M	0.8%	HOLD
33	OKURONKURE THERAPEUTICS INC	1,927,710	$8M	0.7%	NEW
34	SRZNSURROZEN INC	260,000	$8M	0.6%	HOLD
35	ALXOALX ONCOLOGY HLDGS INC	3,184,713	$6M	0.5%	NEW
36	MNPRMONOPAR THERAPEUTICS INC	90,500	$5M	0.4%	HOLD
37	MSLESATELLOS BIOSCIENCE INC	813,666	$5M	0.4%	NEW
38	PEPGPEPGEN INC	2,325,000	$4M	0.3%	HOLD
39	SERASERA PROGNOSTICS INC	1,650,440	$3M	0.3%	HOLD
40	TENXTENAX THERAPEUTICS INC	208,333	$3M	0.3%	HOLD
41	VRDNVIRIDIAN THERAPEUTICS INC	166,288	$3M	0.3%	TRIM −83%
42	TILINSTIL BIO INC	292,743	$2M	0.2%	HOLD
43	KTTAPasithea Therapeutics Corp	2,100,000	$2M	0.1%	HOLD
44	CMPSCOMPASS PATHWAYS PLC	200,000	$1M	0.1%	NEW
45	BOLTBOLT BIOTHERAPEUTICS INC	72,414	$292,553	0.0%	HOLD
46	DTILPRECISION BIOSCIENCES INC	4,675	$25,713	0.0%	HOLD

Position trends· top 15 holdings · shares held over 6 quarters

green added · red trimmed

Security

2024-Q4

2025-Q1

2025-Q2

2025-Q3

2025-Q4

2026-Q1

Latest value

ERASERASCA INC

6.8M

9.3M

12.2M

$197M

PRAXPRAXIS PRECISION MEDICINES I

—

168K

199K

329K

339K

$109M

TERNS PHARMACEUTICALS INC

6.9M

5.3M

1.3M

$70M

TRVITREVI THERAPEUTICS INC

3.5M

4.5M

5.1M

$61M

DBVTDBV TECHNOLOGIES S A

32K

—

1.1M

2.5M

2.7M

$56M

CMPXCOMPASS THERAPEUTICS INC

3.6M

6.0M

9.5M

$50M

TNGXTANGO THERAPEUTICS INC

—

600K

777K

2.2M

$45M

SABSSAB BIOTHERAPEUTICS INC

—

11.4M

$44M

CRVSCORVUS PHARMACEUTICALS INC

2.2M

2.8M

$41M

DRUGBRIGHT MINDS BIOSCIENCES INC

252K

502K

557K

$41M

SVASINOVAC BIOTECH LTD

—

5.9M

$38M

DNTHDIANTHUS THERAPEUTICS INC

—

354K

$30M

DYNDYNE THERAPEUTICS INC

1.1M

2.6M

1.6M

$28M

ABVXABIVAX SA

—

359K

240K

$27M

NERVMINERVA NEUROSCIENCES INC

—

4.3M

$26M

Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.

☆Vivo Capital, LLC